Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants

NCT05033561 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

905

Enrollment

OTHER

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: nOPV2

Sponsor

Fidec Corporation

Collaborators

[object Object]